Bright Minds Biosciences Inc. Insider Ownership | DRUG

Insider Holdings by Owner

950.00K Shares

Insider Ownership Statistics

as of 30 Sep, 2026

Insider Ownership

13.81%

■0% pp QoQ

Shares Held by Insiders

950.00K

filed for Sep 2026

■0.00% QoQ

Shares Outstanding

6.88Mn

6,878,051 shares

Direct Holdings

0

Indirect: 950.00K

Net Shares Traded (QoQ)

0

no net change in Sep 2026

Insiders Holding Shares

1

with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold

Latest quarter —

Net over range —

Buying quarters —

Insider Ownership Summary

Updated Oct 5, 2026

Over the past year, DRUG insiders sold $9.79 million of stock (109.33K shares) on the open market and bought none.

The largest open-market sales of DRUG in the past 12 months were by Cormorant Asset Management, LP, totaling $9.79 million (109.33K shares), most recently on April 28, 2026.
Business Quant data shows Bright Minds Biosciences insiders holding 950K shares in total in their latest Form 4 filings, or 13.81% of the 6.88Mn shares outstanding; that total is unchanged from 950K shares at the end of Q2 2026 and down 10.32% from 1.06Mn shares at the end of Q3 2025.
None of the 950K shares held by Bright Minds Biosciences insiders is held directly; all are held through trusts, partnerships, family members or other entities.
DRUG's largest insider shareholder, per the latest Form 4 filings, is Cormorant Asset Management, LP (950K shares).
These insider figures for Bright Minds Biosciences are based on Form 4 filings through April 30, 2026.

Form 4 Holdings

Insiders Holding DRUG

Insiders 1

Shares held 950.00K

Of outstanding 13.81%

#	Insider	Position	Direct	Indirect	Total	Share of Insiders	Last Filed
1	Asset Management, Lp Cormorant	Other	0	950,000	950,000	100.0%	30 Apr, 2026

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

13 Insider Transactions

Source SEC Form 4

Latest quarter Sep 2026

Date	Insider	Position	Transaction	Shares	Price	Value	Shares Held After	Ownership
28 Apr, 2026	Asset Management, Lp Cormorant	Other	Disposed S	109,331	$89.50	$9.79Mn	950,000	Indirect
04 Nov, 2024	Asset Management, Lp Cormorant	TenPercentOwner	Acquired P	184,331	$21.70	$4.00Mn	1,059,331	Indirect
15 Oct, 2024	Asset Management, Lp Cormorant	TenPercentOwner	Acquired P	238,097	$4.53	$1.08Mn	690,506	Indirect
15 Oct, 2024	Asset Management, Lp Cormorant	TenPercentOwner	Acquired P	63,173	$5.92	$374.24K	753,679	Indirect
15 Oct, 2024	Asset Management, Lp Cormorant	TenPercentOwner	Acquired P	33,343	$6.42	$214.22K	787,022	Indirect
15 Oct, 2024	Asset Management, Lp Cormorant	TenPercentOwner	Acquired P	8,900	$7.31	$65.02K	795,922	Indirect
15 Oct, 2024	Asset Management, Lp Cormorant	TenPercentOwner	Acquired P	2,600	$8.80	$22.89K	798,522	Indirect
15 Oct, 2024	Asset Management, Lp Cormorant	TenPercentOwner	Acquired P	2,700	$9.26	$25.01K	801,222	Indirect
15 Oct, 2024	Asset Management, Lp Cormorant	TenPercentOwner	Acquired P	19,169	$11.72	$224.60K	820,391	Indirect
15 Oct, 2024	Asset Management, Lp Cormorant	TenPercentOwner	Acquired P	4,609	$12.35	$56.93K	825,000	Indirect
16 Oct, 2024	Asset Management, Lp Cormorant	TenPercentOwner	Acquired P	39,743	$23.22	$922.63K	864,743	Indirect
16 Oct, 2024	Asset Management, Lp Cormorant	TenPercentOwner	Acquired P	7,150	$24.03	$171.81K	871,893	Indirect
16 Oct, 2024	Asset Management, Lp Cormorant	TenPercentOwner	Acquired P	3,107	$25.22	$78.36K	875,000	Indirect

Bright Minds Biosciences DRUG Insider Ownership